Connelly Stephen 4

What Happened
Stephen Connelly, President and Chief Scientific Officer of Equillium, sold a total of 230,975 shares of EQ stock in two open‑market dispositions. On June 4, 2026 he sold 200,000 shares (reported at a weighted avg. price of $3.16) for $632,760; on June 5, 2026 he sold 30,975 shares (weighted avg. $2.94) for $91,070. These were sales (disposals), not purchases or option exercises.

Key Details

• Transaction dates: June 4, 2026 (200,000 shares) and June 5, 2026 (30,975 shares). Transaction code: S (Sale/Disposition).
• Reported proceeds: $632,760 (6/4 sale) and $91,070 (6/5 sale); total ≈ $723,830.
• Reported prices are weighted averages; June 4 sales ranged from $3.07 to $3.345 (F1), June 5 sales ranged from $2.83 to $3.06 (F2). The filer offers to provide per‑trade detail on request.
• Shares owned after the transactions: not specified in the information you provided from the filing.
• Filing timeliness: Form 4 was filed on 2026‑06‑05 for transactions on 6/4 and 6/5 — within normal short reporting windows (not flagged as late).

Context
These were straightforward open‑market sales by an executive. Sales are routine insider activity and do not, by themselves, indicate company performance or insider sentiment. The filing shows weighted average prices and multiple trades rather than a single block sale.